| Financial Year |
March 31 2023 |
| Monetary Funds |
1,185,285,221.28 |
| Held-for-trading Financial Assets |
1,244,893,302.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
209,148,847.60 |
| Advances to Suppliers |
51,129,504.92 |
| Other Receivables |
62,658,779.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,671,672.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
987,866,100.96 |
| Total Current Assets |
3,885,653,429.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
451,820,701.87 |
| Investment Properties |
7,851,538.12 |
| Fixed Assetes |
205,473,157.23 |
| Under-construction Projects |
97,424,736.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,485,274.00 |
| R&D expenses |
-- |
| Goodwill |
356,192,366.59 |
| Long-Term Deferred and Prepaid Expenses |
67,496,008.82 |
| Deferred Income Tax Assets |
8,123,631.78 |
| Other Non-Current Assets |
24,988,787.67 |
| Sub-Total of Non-Current Assets |
1,497,114,808.87 |
| Total Assets |
5,382,768,238.63 |
| Short-Term Loans |
6,000,000.00 |
| Trading Financial liabilities |
9,251,468.03 |
| Notes Payable |
-- |
| Accounts Payable |
66,882,693.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,397,669.43 |
| Taxes Payable |
54,175,210.64 |
| Interest Payable |
5,683.42 |
| Dividend Payable |
7,376,542.80 |
| Other payables |
122,453,597.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,383,836.89 |
| Other Current Liabilities |
3,816,148.45 |
| Sub-Total of Current Liabilities |
405,041,143.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
97,401.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,120,016.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
169,798,770.56 |
| Total Liabilities |
574,839,914.04 |
| Paid-In Capital(Or Share Stock) |
894,826,637.00 |
| Capital Surplus |
1,547,791,446.08 |
| Surplus Reserve |
250,130,651.43 |
| LESS:Treasury Stock |
56,199,804.47 |
| Undistributed Profits |
1,768,080,324.22 |
| Minority Stockholder's Interest |
403,299,070.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,404,629,254.26 |
| Owner's Equity（Stockholder's Equity） |
4,807,928,324.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,382,768,238.63 |
